In particular, the association between KLHL23 alterations and clinical prognosis has been of interest in previous studies, but our research took this a step further by linking these alterations to the extent of immune cell infiltration, suggesting a possible immunomodulatory role of KLHL23 in the tumor microenvironment. The gene discussed is KLHL23; the disease is neoplasm.